Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
1.300
+0.060 (4.84%)
After-hours: Mar 28, 2025, 7:30 PM EDT
Fractyl Health Stock Forecast
GUTS's stock price has decreased by -82.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fractyl Health stock has a target of 10, which predicts an increase of 706.45% from the current stock price of 1.24.
Analyst Consensus: Buy
* Price targets were last updated on Feb 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Fractyl Health is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 1 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $10 | Buy | Maintains | $18 → $10 | +706.45% | Feb 3, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +1,351.61% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
n/a
from 93.00K
Revenue Next Year
n/a
EPS This Year
-1.85
from -1.62
EPS Next Year
-1.80
from -1.85
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.90 | -1.85 | -0.91 |
Avg | -1.85 | -1.80 | -0.89 |
Low | -1.77 | -1.72 | -0.85 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.